InNexus Biotechnology Inc. CEO to Give Keynote Presentation at Toronto Stock Exchange Group Roadshow

BRITISH COLUMBIA, Canada--(BUSINESS WIRE)--InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, is pleased to announce that Jeff Morhet, Chairman and CEO, will be a keynote speaker at the Toronto Stock Exchange Group Roadshow, being held at the Arizona Biltmore Resort & Spa in Scottsdale, Arizona on Tuesday, October 2, 2007. Mr. Morhet is scheduled to present at 12:00 PM PT in the Grand Ballroom. The presentation will include an overview of the Company’s business strategy and future milestones. InNexus’ Chief Financial Officer, Wade Brooksby, will also be in attendance.

MORE ON THIS TOPIC